AI-guided DNA switches for precise, safe, and adaptive cancer therapy
Project Overview
OncoSwitch is developing an AI-guided platform that designs DNA switches capable of activating therapeutic genes only in cancer cells while remaining silent in healthy tissue.
Our system integrates high-throughput MPRA data with machine learning to iteratively design, test, and optimize regulatory sequences.
Within 18 months, the platform aims to deliver 3–5 patentable DNA switches and launch collaborations with biotech and pharma partners.
Key Resources
Type
Description
Main project presentation
Project summary
For investors
For scientists
1–2 min visual presentation
Product milestones
Financial Model & P&L
Our Core Team
Founder & CEO
Malika Gallyamova
- MSc Al & Computer Science, University of Birmingham
- Expert in networking and communications
- Experience managing teams and complex processes
Scientific CТО
Vitalii Volkov
- MSc Al & Computer Science, University of Birmingham
- Graduate of Pirogov Russian National Research Medical University
- Senior Bioinformatician at Genomed
Get in Touch with Us
Oops! Something went wrong while submitting the form.
